Skip to content
Lower risk Drug recall · FDA · Published December 30, 2024

Granules Metformin ER Tablets Recall: Paracetamol Contamination Risk

Granules Pharmaceuticals recalls 500mg Metformin ER tablets (1000-count) due to paracetamol contamination. Rx-only product manufactured in India, shipped to US. Consumers should check NDC 82009-117-10 and lot number 4911311A.

🇺🇸 FDA recall #D-0192-2025DrugGranules ›
Take action

Contact the company

Recalling firmGranules Pharmaceuticals Inc.3701 Concorde Pkwy · Chantilly, VA 20151-1126
✎ GovInfoNow plain-language explainer

What happened, in plain English

Granules Pharmaceuticals recalled 500mg Metformin Hydrochloride Extended-Release Tablets because a paracetamol tablet was found inside the bottle. This contamination could cause unintended medication effects if taken. The product is prescription-only and sold in 1000-count bottles. Read more at govinfonow.com/recall/32340-granules-metformin-er-tablets-recall-paracetamol-contamination-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32340-granules-metformin-er-tablets-recall-paracetamol-contamination-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0192-2025

Cite this page

“Granules Metformin ER Tablets Recall: Paracetamol Contamination Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32340-granules-metformin-er-tablets-recall-paracetamol-contamination-risk. Based on FDA recall #D-0192-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0192-2025%22&limit=1).

Why it’s dangerous

The recall involves a paracetamol tablet (acetaminophen) being found inside a bottle of Metformin ER tablets. This means someone could accidentally take the paracetamol tablet instead of the metformin, potentially causing liver damage or other adverse effects. The product is prescription-only and intended for diabetes treatment.

Who’s affected

Prescription patients who received the specific 500mg Metformin ER tablets from Granules India Limited with NDC 82009-117-10 and lot number 4911311A. People taking metformin for diabetes are most at risk if they accidentally consume the paracetamol tablet.

How to tell if you have this one

Check for the NDC code 82009-117-10 on the bottle label. Look for the lot number 4911311A on the packaging. The product was manufactured in India and shipped to the US by Quallent Pharmaceuticals Health LLC.

  • Brand
    Granules
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the NDC code 82009-117-10 and lot number 4911311A on the bottle.

Where it went and when

Where it was distributed

Distributed in Ohio.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: yesOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distributor in OH.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Ohio.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Dec 30, 202412. FDA classified it Class II: Jan 8, 202523. Published in FDA’s Enforcement Report: Jan 15, 202534. FDA terminated the recall: Jan 15, 2026420242026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Granules recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0192-2025 (December 30, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0192-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA